Pfizer move on Astra threatens UK science, lawmakers say

Comments (2)
hamish001 wrote:

One problem with Pfizer’s promise_allegedly legally binding_ to maintain 20% of its overall research effort in the UK is that this would not prevent it from ‘migrating’ the most promising lines of research,along with the scientists, back to its facilities in the States. Less promising lines of research could still take place in the UK,thus fulfilling the 20% criterion.
Another issue is that of ‘open market reciprocity’ whereby I believe the US Congress would be most unlikely to approve such a take-over were AstraZeneca the bidder. This leads me to assert that this bid,as it stands, should be blocked on ‘national interest’ grounds.
Finally,the tax implications should the deal succeed, will certainly raise eyebrows in Congress!

May 15, 2014 1:03pm EDT  --  Report as abuse
JS2009 wrote:

So what,
England may have been lack of ingenierirs, but not here in Uppsala.
Ex.pfiser bought up Pharmacia AB. 5000 jobs. Ufter that Upjohn bid we created 20 000 tghings.

Pfiser is boying swedish knowhow.

May 15, 2014 5:02pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.